MASI
Masimo Corporation
NASDAQ: MASI · HEALTHCARE · MEDICAL DEVICES
$178.46
-0.03% today
Updated 2026-04-29
Market cap
$9.34B
P/E ratio
46.47
P/S ratio
6.12x
EPS (TTM)
$3.84
Dividend yield
—
52W range
$126 – $179
Volume
1.6M
Masimo Corporation (MASI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-9.92%
Operating margin
18.50%
ROE
23.40%
ROA
8.86%
Debt/equity
0.72x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $224.34M | $181.83M | 72.52% | 137.71% | 81.05% |
| 2007 | $256.29M | $42.26M | 71.28% | 26.12% | 16.49% |
| 2008 | $307.07M | $31.93M | 70.87% | 23.24% | 10.40% |
| 2009 | $349.12M | $53.23M | 71.27% | 23.55% | 15.25% |
| 2010 | $405.41M | $73.53M | 70.44% | 26.20% | 18.14% |
| 2011 | $438.99M | $63.70M | 67.00% | 19.71% | 14.51% |
| 2012 | $493.23M | $62.27M | 66.15% | 17.28% | 12.63% |
| 2013 | $547.25M | $58.38M | 65.57% | 14.57% | 10.67% |
| 2014 | $586.64M | $72.52M | 66.61% | 17.64% | 12.36% |
| 2015 | $630.11M | $83.30M | 65.07% | 19.08% | 13.22% |
| 2016 | $712.90M | $300.67M | 67.10% | 61.15% | 42.18% |
| 2017 | $790.25M | $131.62M | 66.06% | 23.26% | 16.66% |
| 2018 | $858.29M | $193.54M | 66.98% | 24.24% | 22.55% |
| 2019 | $937.84M | $196.22M | 67.09% | 23.59% | 20.92% |
| 2020 | $1.14B | $240.30M | 64.96% | 22.37% | 21.01% |
| 2021 | $1.24B | $229.60M | 65.24% | 22.26% | 18.53% |
| 2022 | $2.04B | $143.50M | 52.01% | 10.32% | 7.05% |
| 2023 | $2.05B | $81.50M | 49.00% | 6.66% | 3.98% |
| 2024 | $2.09B | $-304.90M | 47.96% | -12.73% | -14.56% |
| 2025 | $1.53B | $-151.50M | 61.90% | 20.49% | -9.92% |